CD8A and neoplasm: Furthermore, the supernatant derived from GPX4‐loaded oncolytic vaccinia virus (OVV‐GPX4) can significantly strengthen the function of CD8+ T cells in tumour suppression via decreasing the CD36 expression and reducing lipid peroxidation ex vivo, reinforcing the tumour‐killing effects of immunotherapy in Panc02 mouse model.161